SEC Form 4 · accession 0001209191-16-088692
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin G Lafond
Officer — Vice Pres., Treasurer & CAO
Period of report
Dec 31, 2015
Accepted (ET)
Jan 5, 2016 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2015 | A | 28,000 | $0.00 | A | 28,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F19,334 shares shall vest on 12/31/2016; 9,333 shares shall vest on each of 12/31/2017 and 12/31/2018.